We were delighted to hear the recent news that Alan Parker, our programme lead for targeted therapeutics, has been awarded a personal chair at Cardiff University. A personal chair is awarded to an individual in recognition of their high levels of achievements and standing in their discipline and comes with the title Professor.
Prof. Parker said, "I’m naturally over the moon to have been promoted – though I think it will take some while for me to get over the imposter syndrome associated with being called Professor Parker! I am conscious that this promotion is down to the immense talent and dedication of the amazing group of scientists I have worked with, past and present in my team – without their drive and commitment this would not have been possible. I am also immensely grateful to Cancer Research UK, Cancer Research Wales and Tenovus Cancer Care – it is genuinely humbling to know how hard they work to generate their income, and even more so that they see fit to invest that hard earned funding in our lab.
"Since learning of my promotion, I have been keen to stress we shouldn’t dwell on it too long. A momentary celebration is welcome, of course, especially in what has been a traumatic year for us all, but the most important stuff lies ahead of us, not behind us. This is very much the start of the journey, not the end, and the time is approaching where we must focus on translating our research into real patient benefit. I look forward to working collaboratively with scientists, clinicians, industrial partners, funders and regulators over the coming months and years to deliver this ambition.”
We would like to offer Alan congratulations from all of us at the centre on this greatly deserved promotion.